GM&C Life Sciences Fund is a venture capital firm in Cheshire that focuses on life science businesses. It is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures"). It is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships. Founded 2015 in Alderley Edge, Cheshire, United Kingdom, it invests in seed rounds, angel rounds and venture rounds. Its portfolio companies include AMR Centre, Acea Health, Biorelate, Clin-e-cal, CLYZ Labs, Manchester Imaging, Maxwellia, Pencil Biosciences and Renephra. As of March 2020, GM&C Life Sciences Fund has made 27 investments. Their most recent investment was on December 12, 2019, when Pencil Biosciences raised £500K.
Documentaries, videos and podcasts